What advice does Amit Gattani have for neuroendocrine patients

Amit Gattani's Perspective on Neuroendocrine Cancer

Based on the CancerPatientLab webinar series, Amit Gattani—a stage 4 cancer patient with neuroendocrine differentiation—offers several important insights for patients navigating this disease:

Key Advice from Amit's Experience

1. Prioritize Neuroendocrine Control Above All Else

Amit's most direct advice: "If there is something related to neuroendocrine control, that is what is of most interest."

He emphasizes that when you have neuroendocrine disease, this aggressive component should be your primary focus in treatment planning. While other biomarkers and treatment options exist, controlling the neuroendocrine progression is the urgent priority.

2. Assemble a Multidisciplinary Medical Team

Amit works with multiple specialists and consultants, including:

• Oncologists focused on neuroendocrine expertise
• Specialists in targeted therapies (like those at UCSD and other academic centers)
• Experts in biomarker interpretation
• Integrative medicine providers

He demonstrates that complex cases benefit from diverse expert perspectives rather than relying on a single provider.

3. Actively Engage in Your Own Care

Amit participates in:

• Support groups (PCF on Facebook, ZeroCancer)
• Patient communities and hackathons
• Detailed discussions with his medical panel
• Consultation with specialized labs for biomarker analysis

His philosophy: Patients who are actively engaged in understanding their disease and treatment options tend to get better outcomes.

4. Be Aware of Testing Limitations

Amit notes an important reality: "There's a very low consistency between Guardant and Tempus" (two major liquid biopsy companies). This means:

• Don't rely on a single test result
• Consider multiple testing approaches
• Understand that genomic testing has limitations, especially for neuroendocrine tumors
• Be prepared to seek additional testing if needed

5. Consider Complementary Approaches for Quality of Life

While maintaining focus on medical treatment, Amit uses:

• Acupuncture (twice weekly, based on his integrative oncologist's recommendation)
• Integrative oncology approaches
• Palliative care strategies to manage symptoms and maintain quality of life

He's open to exploring complementary therapies like frequency-specific microcurrent for pain management, viewing these as supporting—not replacing—standard treatment.

Treatment Considerations Amit Discusses

According to the webinars, Amit and his medical team have discussed:

• Etoposide for neuroendocrine control
• PARP inhibitors (though these are secondary to neuroendocrine-focused approaches)
• Chemotherapy combinations tailored to his specific biomarkers
• Radiation therapy for localized disease progression
• Peptide receptor radionuclide therapy (PRRT) with lutetium Lu 177 dotatate (if SSTR-positive)

Important Context from NCCN Guidelines

According to the NCCN Guidelines for Neuroendocrine Tumors, treatment approaches for advanced disease typically include:

• Somatostatin analogs (octreotide LAR or lanreotide) for symptom control
• Systemic therapies based on disease characteristics (everolimus, temozolomide, or chemotherapy)
• PRRT with lutetium Lu 177 dotatate (if SSTR-positive and disease is progressing)
• Clinical trials (often preferred as first-line options)

Amit's Core Message

Amit's overarching advice is that neuroendocrine cancer patients should:

1. Stay informed about their specific disease biology
2. Seek expert consultation from specialists experienced with neuroendocrine tumors
3. Maintain realistic optimism while being proactive about treatment decisions
4. Balance aggressive treatment with quality-of-life considerations
5. Connect with community for support and shared learning

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.